Vytorin is the trade name for the generic combination of ezetimibe and simvastatin, a prescription drug used to control cholesterol.
Vytorin alone is not capable of controlling heart disease, but Vytorin taken as part of a whole-body cholesterol reduction plan can prove very effective. Vytorin use should also be combined with proper exercise, diet, weight control, and possibly use of other medications. Vytorin is most effective when taken precisely as prescribed by a doctor, and when all instructions for drug use and lifestyle enhancements are followed.
Before a patient starts on a protocol of Vytorin, they should discuss all current medication usage and medical conditions to be sure Vytorin is safe for them. Specifically, patients should tell their doctor:
• Of any allergies they have, particularly allergy to "statin" drugs
• About any active liver disease, or history of liver or kidney disease
• Of history of heart disease
• About metabolic disorders, poorly controlled diabetes, and underactive thyroid
• About all serious medical conditions, including trauma, surgery, serious illness, blood disorders, seizures or low blood pressure
Pregnant women are cautioned not to take Vytorin. Simvastatin may harm unborn babies. Women of child-bearing age are strongly urged to take birth control while on Vytorin. Any woman who is, or thinks she may be pregnant should call their doctor right away.
Side effects and allergy may occur with Vytorin use; patients should become familiar with these symptoms, and limit alcohol consumption as it may exacerbate side effects caused by Vytorin.
Average dosages of Vytorin start at pill combination of Vytorin 10 20 — that is, 10 mg ezetimibe and 20 mg simvastatin. The dose is taken once each day in the evening (with or without food). Lower doses of Vytorin 10 10 combination may be appropriate for lesser cholesterol problems, and more aggressive treatment for higher levels may be given at combinations of Vytorin 10 40.
If the desired response is not achieved, the dosage may be incrementally increased up to a maximum of Vytorin 10 80 daily.
If a dose of Vytorin is missed, it should be taken as soon as remembered. If it is close to the time of the next dose, the missed dose should be skipped and the regular schedule resumed to avoid overdosing. There are no specifically identified effects of overdosing on Vytorin; however, overdose of any drug has the potential to be dangerous. When an overdose is suspected, patients should contact their doctor and poison control center.
Vytorin should be stored at room temperature (68-77 degrees) away from moisture and light, and always kept away from children and pets.
Vytorin is a prescription drug used to control cholesterol. Generically, it is known by its combined ingredients, ezetimibe and simvastatin.
Vytorin works to lower levels of 'bad' cholesterol (low-density lipoprotein, or LDL), while raising levels of good cholesterol (high-density lipoprotein, or HDL). Vytorin does this by reducing the amount of fat absorbed by the body, and by blocking cholesterol production.
Treating Cholesterol Levels with Vytorin
Healthy cholesterol levels decrease the risk for hardened arteries, heart attack and blood circulation problems. There are times when Vytorin may be prescribed for uses other than those listed on its labeling; generally, Vytorin is prescribed to treat high cholesterol and high cholesterol (and/or triglyceride) levels that are genetically inherited.
Vytorin is usually prescribed following a change in lifestyle (diet, exercise); when lifestyle changes are not enough to lower cholesterol levels, Vytorin is added to the previously developed plan. Vytorin is intended to be a part of a cholesterol management plan, not a 'fix-all' drug in itself.
It may take up to 2 weeks before an improvement in cholesterol levels is noted; dosages may need to be increased if not found effective after that time. Vytorin use may affect or be affected by existing medical conditions and medication use; some drugs cannot be taken with Vytorin at all. Therefore, it is important to thoroughly discuss past and present medical conditions and all medication use with the prescribing doctor prior to use.
Patients currently using any of the following medications must inform their doctor:
• Cholestyramine, colestipol, colesevelam
• Antibiotic medications
• HIV medications
Vytorin Side Effects
Patients using Vytorin must also be on the lookout for symptoms of side effects and allergies (although allergy to Vytorin is unlikely). Such symptoms include:
• Muscle pain or tenderness
• Weakness, may be accompanied by flu-like symptoms, fever, and dark-colored urine
• Decrease in urine production
• Vision changes (blurry vision)
these are serious Vytorin side effects that require immediate medical attention; patients should stop taking the drug and call their doctor. Less serious Vytorin side effects, which should be reported while still taking Vytorin, include:
• Stomach upset, nausea, diarrhea
• Sore throat, cough, nasal congestion
• Rash and/or itching
• Joint or back pain
Symptoms of Vytorin allergy include:
• Difficulty breathing
As with all drugs, the benefit of Vytorin use must outweigh any mal-effects, discomfort, or potential for harm. Clear, regular, accurate communication with medical professionals is the surest way to ensure a safe, effective, positive outcome with this drug.
Additional Vytorin Drug Resources
Vytorin Information from Drugs.com
ezetimibe and simvastatin (Vytorin) - medication uses
Vytorin (Ezetimibe & Simvastatin) drug description - prescription
Vytorin 10-80 Oral Uses and How to Use
Vytorin side effects (Ezetimibe & Simvastatin)
Ezetimibe/simvastatin - Wikipedia
Infectious Diseases / Bacteria / Viruses News
Safety And Efficacy Of The Use Of Intravesical And Oral Pentosan Polysulfate Sodium For Interstitial Cystitis
UroToday.com - Clinical Trial: In an effort to improve treatment results for BPS/IC, Davis and colleagues from Glendora, California and Pittsburgh in a study supported by Ortho-McNeil examined the safety and efficacy of a combination of intravesical and oral pentosan polysulfate sodium (PPS) in the treatment of interstitial cystititis. Read More...
Focus Diagnostics Launches Laboratory Test For Chikungunya Virus
Focus Diagnostics, Inc., the infectious disease diagnostics company of Quest Diagnostics (NYSE: DGX), today announced the first laboratory developed test in the U.S. for detecting the mosquito-borne chikungunya virus. Commercial availability of the molecular polymerase chain reaction (PCR) test will enable physicians in the U.S. to test patients who may have contracted the virus, such as individuals returning from regions in Africa and Asia where chikungunya is endemic. Read More...
Global Network Of Human-Pathogen Protein Interactions Created And Explored
The first global analysis of the interactions between human proteinsand the proteins of viruses of other pathogens has recently beendeveloped, as reported on February 15 in the open-access journal PLoSPathogens, a part of the Public Library ofScience. Read More...
Novel Approach Strips Staph Of Virulence
An international team of researchers supported by the National Institutes of Health (NIH) has blocked staph infections in mice using a drug previously tested in clinical trials as a cholesterol lowering agent. The novel approach, described in the February 14 online edition of Science, could offer a new direction for therapies against a bacterium that's becoming increasingly resistant to antibiotics. Read More...
| Vytorin Side Effects